Report at the Rothschild Hospital in Paris, where since last September, the date on which maternity was modernized, the professor of this service has chosen to propose the RU 486 or Mifegyne abortive pill to her patients wishing to abort. Comment on pictures of the maternity hospital Rothschild (corridors, staff, empty rooms). Interview with Dr Danièle KRULIK about the services offered to women and their reactions when taking UK treatment. Interview with Dr Edouard SAKIZ, Chairman of the Board of Directors of Roussel-Uclaf: 35,000 women in France have already used the Mifegyne manufactured by Roussel-Uclaf. Image of a box and stamps of Mifegyne (Mifepristone). Title bench of the order of 28 December 1988 relating to Mifegyne 200mg.
Accessible rights for all uses, in the whole world, in accordance with our T&Cs.
Digital Publication : use for editorial publications - to inform the general public or illustrate the news - for digital broadcast on services, valid for 5 years.
Corporate/Brand content : use for the presentation and promotion of an image, brand, history and values of the Contracting Partner company - or, where applicable, the Beneficiary - for digital broadcast on its services and/or for Events, valid for 1 year.
Cultural Licence : use for cultural purposes and restricted to members of the cultural network. Digital publication for a term of 5 (years) and Events for a term of 1 (one) year from the order payment date.